RF (radiofrequency) ablation promising for head and neck cancers:

Radiofrequency (RF) ablation therapy could significantly reduce pain and discomfort experienced by patients with advanced tumours in the mouth and throat, according to the first formal study of the technique in patients with head and neck cancer. The study, lead by Randall Owen, of Montefiore Medical Center, in New York, appears in Head & Neck (August 2002). RF ablation controlled the cancer locally, led to minimal damage to healthy surrounding tissue and was palliative, Dr Owen reported. According to the National Cancer Institute, head and neck cancers account for around 3% of all cancers in the US.